{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T14:21:32Z","timestamp":1791728492099,"version":"4.3.4"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82474506"],"award-info":[{"award-number":["82474506"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82205114"],"award-info":[{"award-number":["82205114"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403377"],"award-info":[{"award-number":["82403377"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2023ZD0510300"],"award-info":[{"award-number":["2023ZD0510300"]}]},{"DOI":"10.13039\/100018904","name":"Beijing Xisike Clinical Oncology Research Foundation","doi-asserted-by":"publisher","award":["Y-QLQN2025-0226"],"award-info":[{"award-number":["Y-QLQN2025-0226"]}],"id":[{"id":"10.13039\/100018904","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Zhongnanshan Medical Foundation of Guangdong Province","award":["ZNSXS-20250066"],"award-info":[{"award-number":["ZNSXS-20250066"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematol Oncol"],"DOI":"10.1186\/s13045-026-01814-6","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T19:05:19Z","timestamp":1781723119000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cancer-associated fibroblasts and tertiary lymphoid structure orchestrate the spatial architecture of tumor immunity"],"prefix":"10.1186","volume":"19","author":[{"given":"Haijia","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youyang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qintao","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"issue":"12","key":"1814_CR1","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1016\/j.ccell.2025.09.001","volume":"43","author":"X Chen","year":"2025","unstructured":"Chen X, et al. Single-cell resolution spatial analysis of antigen-presenting cancer-associated fibroblast niches. Cancer Cell. 2025;43(12):2224\u2013e22409.","journal-title":"Cancer Cell"},{"issue":"1","key":"1814_CR2","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41392-021-00544-0","volume":"6","author":"J Huang","year":"2021","unstructured":"Huang J, et al. Extracellular matrix and its therapeutic potential for cancer treatment. Signal Transduct Target Ther. 2021;6(1):153.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"1814_CR3","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/s43018-025-00986-3","volume":"6","author":"K Aliazis","year":"2025","unstructured":"Aliazis K, et al. The tumor microenvironment\u2019s role in the response to immune checkpoint blockade. Nat Cancer. 2025;6(6):924\u201337.","journal-title":"Nat Cancer"},{"issue":"1","key":"1814_CR4","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","volume":"9","author":"B Wu","year":"2024","unstructured":"Wu B, et al. Cold and hot tumors: from molecular mechanisms to targeted therapy. Signal Transduct Target Ther. 2024;9(1):274.","journal-title":"Signal Transduct Target Ther"},{"issue":"4","key":"1814_CR5","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1172\/JCI96313","volume":"129","author":"T Gruosso","year":"2019","unstructured":"Gruosso T, et al. Spatially distinct tumor immune microenvironments stratify triple-negative breast cancers. J Clin Invest. 2019;129(4):1785\u2013800.","journal-title":"J Clin Invest"},{"issue":"8","key":"1814_CR6","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1158\/0008-5472.CAN-25-0959","volume":"86","author":"Y Zhang","year":"2026","unstructured":"Zhang Y, et al. NRF1 Induces ApoEhigh Cancer-Associated Fibroblasts to Promote Stemness of Renal Cell Carcinoma. Cancer Res. 2026;86(8):1902\u201319.","journal-title":"Cancer Res"},{"issue":"9","key":"1814_CR7","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41568-024-00728-0","volume":"24","author":"JL Teillaud","year":"2024","unstructured":"Teillaud JL, et al. Tertiary lymphoid structures in anticancer immunity. Nat Rev Cancer. 2024;24(9):629\u201346.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1814_CR8","doi-asserted-by":"publisher","first-page":"e70052","DOI":"10.1111\/imr.70052","volume":"332","author":"R Zhao","year":"2025","unstructured":"Zhao R, Gao D. Innate Immunity and Tertiary Lymphoid Structures. Immunol Rev. 2025;332(1):e70052.","journal-title":"Immunol Rev"},{"issue":"5","key":"1814_CR9","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S1074-7613(00)80199-5","volume":"12","author":"SA Luther","year":"2000","unstructured":"Luther SA, et al. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity. 2000;12(5):471\u201381.","journal-title":"Immunity"},{"issue":"3","key":"1814_CR10","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.ccell.2023.01.010","volume":"41","author":"O Elhanani","year":"2023","unstructured":"Elhanani O, Ben-Uri R, Keren L. Spatial profiling technologies illuminate the tumor microenvironment. Cancer Cell. 2023;41(3):404\u201320.","journal-title":"Cancer Cell"},{"issue":"8036","key":"1814_CR11","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s41586-024-08087-4","volume":"634","author":"CK Mo","year":"2024","unstructured":"Mo CK, et al. Tumour evolution and microenvironment interactions in 2D and 3D space. Nature. 2024;634(8036):1178\u201386.","journal-title":"Nature"},{"key":"1814_CR12","doi-asserted-by":"publisher","first-page":"105003","DOI":"10.1016\/j.ebiom.2024.105003","volume":"101","author":"F Di Modugno","year":"2024","unstructured":"Di Modugno F, et al. Tumoral and stromal hMENA isoforms impact tertiary lymphoid structure localization in lung cancer and predict immune checkpoint blockade response in patients with cancer. EBioMedicine. 2024;101:105003.","journal-title":"EBioMedicine"},{"issue":"1","key":"1814_CR13","doi-asserted-by":"publisher","first-page":"6619","DOI":"10.1038\/s41467-025-61821-y","volume":"16","author":"X Peng","year":"2025","unstructured":"Peng X, et al. Scalable topic modelling decodes spatial tissue architecture for large-scale multiplexed imaging analysis. Nat Commun. 2025;16(1):6619.","journal-title":"Nat Commun"},{"issue":"6","key":"1814_CR14","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.ccell.2021.03.012","volume":"39","author":"S Affo","year":"2021","unstructured":"Affo S, et al. Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations. Cancer Cell. 2021;39(6):866\u2013e88211.","journal-title":"Cancer Cell"},{"issue":"18","key":"1814_CR15","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1158\/0008-5472.CAN-24-3037","volume":"85","author":"JM Flynn","year":"2025","unstructured":"Flynn JM, et al. Plasticity and Functional Heterogeneity of Cancer-Associated Fibroblasts. Cancer Res. 2025;85(18):3378\u201398.","journal-title":"Cancer Res"},{"issue":"3","key":"1814_CR16","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41416-024-02717-4","volume":"131","author":"C Ramos","year":"2024","unstructured":"Ramos C, Gerakopoulos V, Oehler R. Metastasis-associated fibroblasts in peritoneal surface malignancies. Br J Cancer. 2024;131(3):407\u201319.","journal-title":"Br J Cancer"},{"issue":"1","key":"1814_CR17","doi-asserted-by":"publisher","first-page":"6619","DOI":"10.1038\/s41467-022-34395-2","volume":"13","author":"H Luo","year":"2022","unstructured":"Luo H, et al. Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment. Nat Commun. 2022;13(1):6619.","journal-title":"Nat Commun"},{"issue":"1","key":"1814_CR18","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/s41467-023-35793-w","volume":"14","author":"JM Houthuijzen","year":"2023","unstructured":"Houthuijzen JM, et al. CD26-negative and CD26-positive tissue-resident fibroblasts contribute to functionally distinct CAF subpopulations in breast cancer. Nature Communications. 2023;14(1):183.","journal-title":"Nature Communications"},{"issue":"1","key":"1814_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/path.6369","volume":"265","author":"BW Zheng","year":"2025","unstructured":"Zheng BW, Guo W. Multi-omics analysis unveils the role of inflammatory cancer-associated fibroblasts in chordoma progression. J Pathol. 2025;265(1):69\u201383.","journal-title":"J Pathol"},{"issue":"3","key":"1814_CR20","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1158\/0008-5472.CAN-25-4671","volume":"86","author":"L Veghini","year":"2026","unstructured":"Veghini L, Corbo V. Estrogen shapes fibroblast states to limit pancreatic cancer aggressiveness. Cancer Res. 2026;86(3):567\u20138.","journal-title":"Cancer Res"},{"issue":"6","key":"1814_CR21","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1158\/0008-5472.CAN-24-1185","volume":"85","author":"Z Ou","year":"2025","unstructured":"Ou Z, et al. Hypoxia-induced senescent fibroblasts secrete IGF1 to promote cancer stemness in esophageal squamous cell carcinoma. Cancer Res. 2025;85(6):1064\u201381.","journal-title":"Cancer Res"},{"issue":"8","key":"1814_CR22","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","volume":"9","author":"E Elyada","year":"2019","unstructured":"Elyada E, et al. Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts. Cancer Discov. 2019;9(8):1102\u201323.","journal-title":"Cancer Discov"},{"issue":"9","key":"1814_CR23","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.ccell.2021.06.017","volume":"39","author":"C Hutton","year":"2021","unstructured":"Hutton C, et al. Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunity. Cancer Cell. 2021;39(9):1227\u2013e124420.","journal-title":"Cancer Cell"},{"issue":"25","key":"1814_CR24","doi-asserted-by":"publisher","first-page":"7232","DOI":"10.1016\/j.cell.2024.09.024","volume":"187","author":"E You","year":"2024","unstructured":"You E, et al. Disruption of cellular plasticity by repeat RNAs in human pancreatic cancer. Cell. 2024;187(25):7232\u2013e724723.","journal-title":"Cell"},{"issue":"1","key":"1814_CR25","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1038\/s41467-023-39762-1","volume":"14","author":"L Cords","year":"2023","unstructured":"Cords L, et al. Cancer-associated fibroblast classification in single-cell and spatial proteomics data. Nat Commun. 2023;14(1):4294.","journal-title":"Nat Commun"},{"issue":"11","key":"1814_CR26","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1158\/2159-8290.CD-21-1714","volume":"12","author":"JA Grout","year":"2022","unstructured":"Grout JA, et al. Spatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T-cell Exclusion in Human Lung Tumors. Cancer Discov. 2022;12(11):2606\u201325.","journal-title":"Cancer Discov"},{"issue":"1","key":"1814_CR27","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1038\/s41467-023-40850-5","volume":"14","author":"Z Xiao","year":"2023","unstructured":"Xiao Z, et al. Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors. Nat Commun. 2023;14(1):5110.","journal-title":"Nat Commun"},{"issue":"699","key":"1814_CR28","doi-asserted-by":"publisher","first-page":"eadh8005","DOI":"10.1126\/scitranslmed.adh8005","volume":"15","author":"BH Herzog","year":"2023","unstructured":"Herzog BH, et al. Tumor-associated fibrosis impairs immune surveillance and response to immune checkpoint blockade in non-small cell lung cancer. Sci Transl Med. 2023;15(699):eadh8005.","journal-title":"Sci Transl Med"},{"issue":"7934","key":"1814_CR29","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41586-022-05272-1","volume":"611","author":"AT Krishnamurty","year":"2022","unstructured":"Krishnamurty AT, et al. LRRC15(+) myofibroblasts dictate the stromal setpoint to suppress tumour immunity. Nature. 2022;611(7934):148\u201354.","journal-title":"Nature"},{"issue":"1","key":"1814_CR30","doi-asserted-by":"publisher","first-page":"4988","DOI":"10.1038\/s41467-024-49282-1","volume":"15","author":"A Varveri","year":"2024","unstructured":"Varveri A, et al. Immunological synapse formation between T regulatory cells and cancer-associated fibroblasts promotes tumour development. Nat Commun. 2024;15(1):4988.","journal-title":"Nat Commun"},{"issue":"6","key":"1814_CR31","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1158\/2159-8290.CD-20-1484","volume":"12","author":"KM McAndrews","year":"2022","unstructured":"McAndrews KM, et al. Identification of Functional Heterogeneity of Carcinoma-Associated Fibroblasts with Distinct IL6-Mediated Therapy Resistance in Pancreatic Cancer. Cancer Discov. 2022;12(6):1580\u201397.","journal-title":"Cancer Discov"},{"issue":"1","key":"1814_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12943-024-02191-9","volume":"24","author":"BH Jenkins","year":"2025","unstructured":"Jenkins BH, et al. Single cell and spatial analysis of immune-hot and immune-cold tumours identifies fibroblast subtypes associated with distinct immunological niches and positive immunotherapy response. Mol Cancer. 2025;24(1):3.","journal-title":"Mol Cancer"},{"issue":"1","key":"1814_CR33","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1038\/s41467-025-57465-7","volume":"16","author":"J Song","year":"2025","unstructured":"Song J, et al. Antigen-presenting cancer associated fibroblasts enhance antitumor immunity and predict immunotherapy response. Nat Commun. 2025;16(1):2175.","journal-title":"Nat Commun"},{"issue":"1","key":"1814_CR34","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.1038\/s41467-022-32255-7","volume":"13","author":"M Papanicolaou","year":"2022","unstructured":"Papanicolaou M, et al. Temporal profiling of the breast tumour microenvironment reveals collagen XII as a driver of metastasis. Nat Commun. 2022;13(1):4587.","journal-title":"Nat Commun"},{"issue":"1","key":"1814_CR35","doi-asserted-by":"publisher","first-page":"5810","DOI":"10.1038\/s41467-023-41518-w","volume":"14","author":"S Mayer","year":"2023","unstructured":"Mayer S, et al. The tumor microenvironment shows a hierarchy of cell-cell interactions dominated by fibroblasts. Nat Commun. 2023;14(1):5810.","journal-title":"Nat Commun"},{"issue":"11","key":"1814_CR36","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1038\/s41592-024-02463-8","volume":"21","author":"C Zhong","year":"2024","unstructured":"Zhong C, Ang KS, Chen J. Interpretable spatially aware dimension reduction of spatial transcriptomics with STAMP. Nat Methods. 2024;21(11):2072\u201383.","journal-title":"Nat Methods"},{"issue":"1","key":"1814_CR37","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1038\/s41467-024-46504-4","volume":"15","author":"MT Broz","year":"2024","unstructured":"Broz MT, et al. Metabolic targeting of cancer associated fibroblasts overcomes T-cell exclusion and chemoresistance in soft-tissue sarcomas. Nat Commun. 2024;15(1):2498.","journal-title":"Nat Commun"},{"issue":"13","key":"1814_CR38","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.1158\/0008-5472.CAN-17-2928","volume":"78","author":"W Zhang","year":"2018","unstructured":"Zhang W, et al. GFPT2-Expressing Cancer-Associated Fibroblasts Mediate Metabolic Reprogramming in Human Lung Adenocarcinoma. Cancer Res. 2018;78(13):3445\u201357.","journal-title":"Cancer Res"},{"issue":"9","key":"1814_CR39","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1158\/0008-5472.CAN-19-3158","volume":"80","author":"K Ford","year":"2020","unstructured":"Ford K, et al. NOX4 Inhibition Potentiates Immunotherapy by Overcoming Cancer-Associated Fibroblast-Mediated CD8 T-cell Exclusion from Tumors. Cancer Res. 2020;80(9):1846\u201360.","journal-title":"Cancer Res"},{"issue":"1","key":"1814_CR40","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/s41467-018-03347-0","volume":"9","author":"MA Lakins","year":"2018","unstructured":"Lakins MA, et al. Cancer-associated fibroblasts induce antigen-specific deletion of CD8 (+) T Cells to protect tumour cells. Nat Commun. 2018;9(1):948.","journal-title":"Nat Commun"},{"key":"1814_CR41","doi-asserted-by":"crossref","unstructured":"Harryvan TJ et al. Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease cathepsin S. J Immunother Cancer, 2022. 10(3).","DOI":"10.1136\/jitc-2021-003591"},{"key":"1814_CR42","doi-asserted-by":"crossref","unstructured":"Chen J, et al. CD146(+) CAFs mediate immunosuppression in gastric cancer via COL4A1: potential therapeutic targets. J Immunother Cancer. 2025;13(12):e013577.","DOI":"10.1136\/jitc-2025-013577"},{"issue":"1","key":"1814_CR43","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1038\/s41467-023-39953-w","volume":"14","author":"E Koncina","year":"2023","unstructured":"Koncina E, et al. IL1R1(+) cancer-associated fibroblasts drive tumor development and immunosuppression in colorectal cancer. Nat Commun. 2023;14(1):4251.","journal-title":"Nat Commun"},{"issue":"11","key":"1814_CR44","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1016\/j.ccell.2022.09.015","volume":"40","author":"DS Foster","year":"2022","unstructured":"Foster DS, et al. Multiomic analysis reveals conservation of cancer-associated fibroblast phenotypes across species and tissue of origin. Cancer Cell. 2022;40(11):1392-1406.e7.","journal-title":"Cancer Cell"},{"issue":"1","key":"1814_CR45","doi-asserted-by":"publisher","first-page":"10534","DOI":"10.1038\/s41467-024-54975-8","volume":"15","author":"L Veghini","year":"2024","unstructured":"Veghini L, et al. Differential activity of MAPK signalling defines fibroblast subtypes in pancreatic cancer. Nat Commun. 2024;15(1):10534.","journal-title":"Nat Commun"},{"issue":"8045","key":"1814_CR46","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41586-024-08194-2","volume":"637","author":"M Wagner","year":"8045","unstructured":"Wagner M, Nishikawa H, Koyasu S. Reinventing type 2 immunity in cancer. Nature. 8045;637(8045):296\u2013303.","journal-title":"Nature"},{"issue":"1","key":"1814_CR47","doi-asserted-by":"publisher","first-page":"e70059","DOI":"10.1111\/imr.70059","volume":"334","author":"A Cross","year":"2025","unstructured":"Cross A, et al. Role of Fibroblast-Immune Crosstalk in Kidney, Lung, and Skin Tertiary Lymphoid Structures. Immunol Rev. 2025;334(1):e70059.","journal-title":"Immunol Rev"},{"issue":"8052","key":"1814_CR48","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/s41586-024-08426-5","volume":"638","author":"M Amisaki","year":"2025","unstructured":"Amisaki M, et al. IL-33-activated ILC2s induce tertiary lymphoid structures in pancreatic cancer. Nature. 2025;638(8052):1076\u201384.","journal-title":"Nature"},{"key":"1814_CR49","doi-asserted-by":"publisher","first-page":"8280","DOI":"10.1038\/ncomms9280","volume":"6","author":"P Carrega","year":"2015","unstructured":"Carrega P, et al. NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures. Nat Commun. 2015;6:8280.","journal-title":"Nat Commun"},{"key":"1814_CR50","doi-asserted-by":"publisher","first-page":"12651","DOI":"10.1038\/ncomms12651","volume":"7","author":"LH Jackson-Jones","year":"2016","unstructured":"Jackson-Jones LH, et al. Fat-associated lymphoid clusters control local IgM secretion during pleural infection and lung inflammation. Nat Commun. 2016;7:12651.","journal-title":"Nat Commun"},{"key":"1814_CR51","doi-asserted-by":"crossref","unstructured":"Liu SX, et al. Interferon-responsive HEVs drive tumor tertiary lymphoid structure formation and predict immunotherapy response in nasopharyngeal carcinoma. Cell Rep Med. 2025;6(7):102200, 102200.","DOI":"10.1016\/j.xcrm.2025.102200"},{"issue":"4","key":"1814_CR52","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.immuni.2012.06.010","volume":"37","author":"C Benezech","year":"2012","unstructured":"Benezech C, et al. Lymphotoxin-beta receptor signaling through NF-kappaB2-RelB pathway reprograms adipocyte precursors as lymph node stromal cells. Immunity. 2012;37(4):721\u201334.","journal-title":"Immunity"},{"issue":"6","key":"1814_CR53","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/ni.1605","volume":"9","author":"E Scandella","year":"2008","unstructured":"Scandella E, et al. Restoration of lymphoid organ integrity through the interaction of lymphoid tissue-inducer cells with stroma of the T cell zone. Nat Immunol. 2008;9(6):667\u201375.","journal-title":"Nat Immunol"},{"issue":"2","key":"1814_CR54","doi-asserted-by":"publisher","first-page":"605","DOI":"10.7150\/thno.105423","volume":"15","author":"X Wu","year":"2025","unstructured":"Wu X, et al. B cells and tertiary lymphoid structures in tumors: immunity cycle, clinical impact, and therapeutic applications. Theranostics. 2025;15(2):605\u201331.","journal-title":"Theranostics"},{"issue":"4","key":"1814_CR55","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2012.12.005","volume":"38","author":"L Castagnaro","year":"2013","unstructured":"Castagnaro L, et al. Nkx2-5(+)islet1(+) mesenchymal precursors generate distinct spleen stromal cell subsets and participate in restoring stromal network integrity. Immunity. 2013;38(4):782\u201391.","journal-title":"Immunity"},{"issue":"1","key":"1814_CR56","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1038\/s41467-019-09728-3","volume":"10","author":"HW Cheng","year":"2019","unstructured":"Cheng HW, et al. Origin and differentiation trajectories of fibroblastic reticular cells in the splenic white pulp. Nat Commun. 2019;10(1):1739.","journal-title":"Nat Commun"},{"issue":"7","key":"1814_CR57","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/s41590-023-01503-3","volume":"24","author":"M Lutge","year":"2023","unstructured":"Lutge M, et al. Conserved stromal-immune cell circuits secure B cell homeostasis and function. Nat Immunol. 2023;24(7):1149\u201360.","journal-title":"Nat Immunol"},{"issue":"8","key":"1814_CR58","doi-asserted-by":"publisher","first-page":"7194","DOI":"10.1021\/acsnano.2c09619","volume":"17","author":"Z Wen","year":"2023","unstructured":"Wen Z, et al. Nanovaccines Fostering Tertiary Lymphoid Structure to Attack Mimicry Nasopharyngeal Carcinoma. ACS Nano. 2023;17(8):7194\u2013206.","journal-title":"ACS Nano"},{"issue":"5","key":"1814_CR59","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1158\/2159-8290.CD-24-0991","volume":"15","author":"MB Hugaboom","year":"2025","unstructured":"Hugaboom MB, et al. Presence of Tertiary Lymphoid Structures and Exhausted Tissue-Resident T Cells Determines Clinical Response to PD-1 Blockade in Renal Cell Carcinoma. Cancer Discov. 2025;15(5):948\u201368.","journal-title":"Cancer Discov"},{"issue":"3","key":"1814_CR60","doi-asserted-by":"publisher","first-page":"109422","DOI":"10.1016\/j.celrep.2021.109422","volume":"36","author":"AB Rodriguez","year":"2021","unstructured":"Rodriguez AB, et al. Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts. Cell Rep. 2021;36(3):109422.","journal-title":"Cell Rep"},{"issue":"27","key":"1814_CR61","doi-asserted-by":"publisher","first-page":"13490","DOI":"10.1073\/pnas.1905301116","volume":"116","author":"S Nayar","year":"2019","unstructured":"Nayar S, et al. Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology. Proc Natl Acad Sci U S A. 2019;116(27):13490\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"1814_CR62","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/ni.3215","volume":"16","author":"C Benezech","year":"2015","unstructured":"Benezech C, et al. Inflammation-induced formation of fat-associated lymphoid clusters. Nat Immunol. 2015;16(8):819\u201328.","journal-title":"Nat Immunol"},{"issue":"1","key":"1814_CR63","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.immuni.2017.11.020","volume":"48","author":"J Emgard","year":"2018","unstructured":"Emgard J, et al. Oxysterol Sensing through the Receptor GPR183 Promotes the Lymphoid-Tissue-Inducing Function of Innate Lymphoid Cells and Colonic Inflammation. Immunity. 2018;48(1):120\u2013e1328.","journal-title":"Immunity"},{"issue":"1","key":"1814_CR64","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41467-024-54686-0","volume":"16","author":"S Nayar","year":"2025","unstructured":"Nayar S, et al. Molecular and spatial analysis of tertiary lymphoid structures in Sjogren\u2019s syndrome. Nat Commun. 2025;16(1):5.","journal-title":"Nat Commun"},{"issue":"1","key":"1814_CR65","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41467-019-13883-y","volume":"11","author":"S Kimura","year":"2020","unstructured":"Kimura S, et al. Osteoprotegerin-dependent M cell self-regulation balances gut infection and immunity. Nat Commun. 2020;11(1):234.","journal-title":"Nat Commun"},{"key":"1814_CR66","doi-asserted-by":"crossref","unstructured":"Groen-van Schooten TS et al. Mapping the complexity and diversity of tertiary lymphoid structures in primary and peritoneal metastatic gastric cancer. J Immunother Cancer, 2024. 12(7).","DOI":"10.1136\/jitc-2024-009243"},{"issue":"10","key":"1814_CR67","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1038\/s41590-025-02267-8","volume":"26","author":"L Steele","year":"2025","unstructured":"Steele L, et al. A single-cell and spatial genomics atlas of human skin fibroblasts reveals shared disease-related fibroblast subtypes across tissues. Nat Immunol. 2025;26(10):1807\u201320.","journal-title":"Nat Immunol"},{"issue":"9","key":"1814_CR68","doi-asserted-by":"publisher","first-page":"2810","DOI":"10.1016\/j.celrep.2019.10.103","volume":"29","author":"VG Martinez","year":"2019","unstructured":"Martinez VG, et al. Fibroblastic Reticular Cells Control Conduit Matrix Deposition during Lymph Node Expansion. Cell Rep. 2019;29(9):2810-2822.e5.","journal-title":"Cell Rep"},{"issue":"2","key":"1814_CR69","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.cell.2024.10.042","volume":"188","author":"L Onder","year":"2025","unstructured":"Onder L, et al. Fibroblastic reticular cells generate protective intratumoral T cell environments in lung cancer. Cell. 2025;188(2):430-446.e20.","journal-title":"Cell"},{"issue":"1","key":"1814_CR70","doi-asserted-by":"publisher","first-page":"7713","DOI":"10.1038\/s41467-024-52153-4","volume":"15","author":"Y Liu","year":"2024","unstructured":"Liu Y, et al. Single-cell and spatial transcriptome analyses reveal tertiary lymphoid structures linked to tumour progression and immunotherapy response in nasopharyngeal carcinoma. Nat Commun. 2024;15(1):7713.","journal-title":"Nat Commun"},{"issue":"3","key":"1814_CR71","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.immuni.2022.02.001","volume":"55","author":"M Meylan","year":"2022","unstructured":"Meylan M, et al. Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer. Immunity. 2022;55(3):527-541.e5.","journal-title":"Immunity"},{"issue":"1","key":"1814_CR72","doi-asserted-by":"publisher","first-page":"4228","DOI":"10.1038\/s41467-025-59341-w","volume":"16","author":"H Li","year":"2025","unstructured":"Li H, et al. Mature tertiary lymphoid structures evoke intra-tumoral T and B cell responses via progenitor exhausted CD4(+) T cells in head and neck cancer. Nat Commun. 2025;16(1):4228.","journal-title":"Nat Commun"},{"issue":"8","key":"1814_CR73","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.ccell.2024.07.006","volume":"42","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, et al. CCL19-producing fibroblasts promote tertiary lymphoid structure formation enhancing anti-tumor IgG response in colorectal cancer liver metastasis. Cancer Cell. 2024;42(8):1370\u2013e13859.","journal-title":"Cancer Cell"},{"issue":"5","key":"1814_CR74","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1158\/2326-6066.CIR-24-0979","volume":"13","author":"L Gorvel","year":"2025","unstructured":"Gorvel L, et al. Tertiary Lymphoid Structures Are Associated with Enhanced Macrophage Activation and Immune Checkpoint Expression and Predict Outcome in Cervical Cancer. Cancer Immunol Res. 2025;13(5):712\u201328.","journal-title":"Cancer Immunol Res"},{"issue":"11","key":"1814_CR75","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1016\/j.immuni.2025.09.018","volume":"58","author":"P Cakmak","year":"2025","unstructured":"Cakmak P, et al. Spatial immune profiling defines a subset of human gliomas with functional tertiary lymphoid structures. Immunity. 2025;58(11):2847\u2013e28638.","journal-title":"Immunity"},{"key":"1814_CR76","doi-asserted-by":"crossref","unstructured":"Srinivas N et al. Tertiary lymphoid structures in Merkel cell carcinoma facilitate naive and central memory T-cell infiltration linked to immunotherapy response. J Immunother Cancer, 2025. 13(9).","DOI":"10.1136\/jitc-2025-012224"},{"issue":"1","key":"1814_CR77","doi-asserted-by":"publisher","first-page":"10232","DOI":"10.1038\/s41467-024-54145-w","volume":"15","author":"X Wang","year":"2024","unstructured":"Wang X, et al. Spatial transcriptomics reveals substantial heterogeneity in triple-negative breast cancer with potential clinical implications. Nat Commun. 2024;15(1):10232.","journal-title":"Nat Commun"},{"issue":"1","key":"1814_CR78","doi-asserted-by":"publisher","first-page":"10435","DOI":"10.1038\/s41467-025-65421-8","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang Y, et al. Single-cell and spatial transcriptomics implicate a prognostic function of tertiary lymphoid structures in gastric cancer. Nat Commun. 2025;16(1):10435.","journal-title":"Nat Commun"},{"issue":"6","key":"1814_CR79","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.ccell.2025.03.011","volume":"43","author":"Z Tang","year":"2025","unstructured":"Tang Z, et al. Spatial transcriptomics reveals tryptophan metabolism restricting maturation of intratumoral tertiary lymphoid structures. Cancer Cell. 2025;43(6):1025\u2013e104414.","journal-title":"Cancer Cell"},{"key":"1814_CR80","doi-asserted-by":"crossref","unstructured":"Syding LA et al. High Treg and PMN-MDSC densities are a hallmark of tertiary lymphoid structures in fatal cases of cervical cancer. J Immunother Cancer, 2025. 13(9).","DOI":"10.1136\/jitc-2025-012613"},{"issue":"1","key":"1814_CR81","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1038\/s41467-024-47068-z","volume":"15","author":"H Croizer","year":"2024","unstructured":"Croizer H, et al. Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer. Nat Commun. 2024;15(1):2806.","journal-title":"Nat Commun"},{"issue":"11","key":"1814_CR82","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1016\/j.ccell.2024.09.007","volume":"42","author":"IP MacFawn","year":"2024","unstructured":"MacFawn IP, et al. The activity of tertiary lymphoid structures in high grade serous ovarian cancer is governed by site, stroma, and cellular interactions. Cancer Cell. 2024;42(11):1864\u2013e18815.","journal-title":"Cancer Cell"},{"issue":"4","key":"1814_CR83","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/s41590-024-01792-2","volume":"25","author":"JH Chen","year":"2024","unstructured":"Chen JH, et al. Human lung cancer harbors spatially organized stem-immunity hubs associated with response to immunotherapy. Nat Immunol. 2024;25(4):644\u201358.","journal-title":"Nat Immunol"},{"issue":"12","key":"1814_CR84","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1038\/s41590-024-02018-1","volume":"25","author":"R Li","year":"2024","unstructured":"Li R, et al. Cutaneous T cell lymphoma atlas reveals malignant T(H)2 cells supported by a B cell-rich tumor microenvironment. Nat Immunol. 2024;25(12):2320\u201330.","journal-title":"Nat Immunol"},{"issue":"50","key":"1814_CR85","doi-asserted-by":"publisher","first-page":"20212","DOI":"10.1073\/pnas.1320318110","volume":"110","author":"C Feig","year":"2013","unstructured":"Feig C, et al. Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer. Proc Natl Acad Sci U S A. 2013;110(50):20212\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7693","key":"1814_CR86","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, et al. TGFbeta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. 2018;554(7693):544\u20138.","journal-title":"Nature"},{"key":"1814_CR87","doi-asserted-by":"crossref","unstructured":"Sautes-Fridman C, Fridman WH, et al. Tertiary lymphoid structures in the era of cancer immunotherapy. Nat Rev Cancer. 2019;19(6):307\u201325.","DOI":"10.1038\/s41568-019-0144-6"},{"issue":"5","key":"1814_CR88","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.ccell.2026.03.004","volume":"44","author":"E Kirschstein","year":"2026","unstructured":"Kirschstein E, et al. Myofibroblast programming blocks differentiation of TLS-organizing fibroblastic reticular cells in pancreatic cancer. Cancer Cell. 2026;44(5):1080-1096.e11.","journal-title":"Cancer Cell"},{"issue":"2","key":"1814_CR89","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1158\/2159-8290.CD-19-0644","volume":"10","author":"CX Dominguez","year":"2020","unstructured":"Dominguez CX, et al. Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15(+) Myofibroblasts as a Determinant of Patient Response to Cancer Immunotherapy. Cancer Discov. 2020;10(2):232\u201353.","journal-title":"Cancer Discov"},{"issue":"4","key":"1814_CR90","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.jaci.2017.12.998","volume":"142","author":"HW Cheng","year":"2018","unstructured":"Cheng HW, et al. CCL19-producing fibroblastic stromal cells restrain lung carcinoma growth by promoting local antitumor T-cell responses. J Allergy Clin Immunol. 2018;142(4):1257-1271.e4.","journal-title":"J Allergy Clin Immunol"},{"key":"1814_CR91","doi-asserted-by":"crossref","unstructured":"O\u2019Connor RA, et al. Cancer-associated fibroblasts drive CXCL13 production in activated T cells via TGF-beta. Front Immunol. 2023;14:1221532, 1221532.","DOI":"10.3389\/fimmu.2023.1221532"},{"key":"1814_CR92","doi-asserted-by":"crossref","unstructured":"Ware MB, El-Rayes BF, Lesinski GB. Mirage or long-awaited oasis: reinvigorating T-cell responses in pancreatic cancer. J Immunother Cancer. 2020;8(2):e001100.","DOI":"10.1136\/jitc-2020-001100"},{"issue":"1","key":"1814_CR93","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s40425-018-0376-0","volume":"6","author":"MU Mushtaq","year":"2018","unstructured":"Mushtaq MU, et al. Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers. J Immunother Cancer. 2018;6(1):65.","journal-title":"J Immunother Cancer"},{"issue":"1","key":"1814_CR94","doi-asserted-by":"publisher","first-page":"10259","DOI":"10.1038\/s41467-024-54710-3","volume":"15","author":"Y Feng","year":"2024","unstructured":"Feng Y, et al. Spatially organized tumor-stroma boundary determines the efficacy of immunotherapy in colorectal cancer patients. Nat Commun. 2024;15(1):10259.","journal-title":"Nat Commun"},{"issue":"4","key":"1814_CR95","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1002\/hep.30889","volume":"71","author":"K Shigeta","year":"2020","unstructured":"Shigeta K, et al. Dual Programmed Death Receptor-1 and Vascular Endothelial Growth Factor Receptor-2 Blockade Promotes Vascular Normalization and Enhances Antitumor Immune Responses in Hepatocellular Carcinoma. Hepatology. 2020;71(4):1247\u201361.","journal-title":"Hepatology"},{"issue":"5","key":"1814_CR96","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1016\/j.jcmgh.2021.06.023","volume":"12","author":"FR Delvecchio","year":"2021","unstructured":"Delvecchio FR, et al. Pancreatic Cancer Chemotherapy Is Potentiated by Induction of Tertiary Lymphoid Structures in Mice. Cell Mol Gastroenterol Hepatol. 2021;12(5):1543\u201365.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1814_CR97","doi-asserted-by":"crossref","unstructured":"Allen E, et al. Combined antiangiogenic and anti-PD-L1 therapy stimulates tumor immunity through HEV formation. Sci Transl Med. 2017;9(385):eaak9679.","DOI":"10.1126\/scitranslmed.aak9679"},{"issue":"11","key":"1814_CR98","doi-asserted-by":"publisher","first-page":"102395","DOI":"10.1016\/j.xcrm.2025.102395","volume":"6","author":"V Boeker","year":"2025","unstructured":"Boeker V, Kalluri R. Insights into the relevance of targeting fibroblasts to control cancer. Cell Rep Med. 2025;6(11):102395.","journal-title":"Cell Rep Med"},{"issue":"5","key":"1814_CR99","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1158\/0008-5472.CAN-22-1890","volume":"83","author":"T Akiyama","year":"2023","unstructured":"Akiyama T, et al. Stromal Reprogramming through Dual PDGFRalpha\/beta Blockade Boosts the Efficacy of Anti-PD-1 Immunotherapy in Fibrotic Tumors. Cancer Res. 2023;83(5):753\u201370.","journal-title":"Cancer Res"},{"key":"1814_CR100","doi-asserted-by":"crossref","unstructured":"Laise P, et al. Systematic identification and targeting of master regulator checkpoints (MRC) governing tumor microenvironment-mediated immune evasion. J Immunother Cancer. 2025;13(6):eaak9679.","DOI":"10.1136\/jitc-2024-011355"},{"issue":"1","key":"1814_CR101","doi-asserted-by":"publisher","first-page":"4692","DOI":"10.1038\/s41467-018-06654-8","volume":"9","author":"A Chakravarthy","year":"2018","unstructured":"Chakravarthy A, et al. TGF-beta-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure. Nat Commun. 2018;9(1):4692.","journal-title":"Nat Commun"},{"issue":"6","key":"1814_CR102","doi-asserted-by":"publisher","first-page":"101610","DOI":"10.1016\/j.xcrm.2024.101610","volume":"5","author":"P Desai","year":"2024","unstructured":"Desai P, et al. Microenvironment shapes small-cell lung cancer neuroendocrine states and presents therapeutic opportunities. Cell Rep Med. 2024;5(6):101610.","journal-title":"Cell Rep Med"},{"issue":"10","key":"1814_CR103","doi-asserted-by":"publisher","first-page":"102357","DOI":"10.1016\/j.xcrm.2025.102357","volume":"6","author":"N Nishida-Aoki","year":"2025","unstructured":"Nishida-Aoki N, et al. Drug screening in 3D microtumors reveals DDR1\/2-MAPK12-GLI1 as a vulnerability in cancer-associated fibroblasts. Cell Rep Med. 2025;6(10):102357.","journal-title":"Cell Rep Med"},{"key":"1814_CR104","doi-asserted-by":"crossref","unstructured":"Trub M, et al. Fibroblast activation protein-targeted-4-1BB ligand agonist amplifies effector functions of intratumoral T cells in human cancer. J Immunother Cancer. 2020;8(2):e000238.","DOI":"10.1136\/jitc-2019-000238"},{"issue":"1","key":"1814_CR105","doi-asserted-by":"publisher","first-page":"6315","DOI":"10.1038\/s41467-020-19920-5","volume":"11","author":"AL Grauel","year":"2020","unstructured":"Grauel AL, et al. TGFbeta-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts. Nat Commun. 2020;11(1):6315.","journal-title":"Nat Commun"},{"issue":"1","key":"1814_CR106","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/imr.12969","volume":"302","author":"H Arai","year":"2021","unstructured":"Arai H, Sato Y, Yanagita M. Fibroblast heterogeneity and tertiary lymphoid tissues in the kidney. Immunol Rev. 2021;302(1):196\u2013210.","journal-title":"Immunol Rev"},{"issue":"1","key":"1814_CR107","doi-asserted-by":"publisher","first-page":"7010","DOI":"10.1038\/s41467-024-51186-z","volume":"15","author":"M Polonsky","year":"2024","unstructured":"Polonsky M, et al. Spatial transcriptomics defines injury specific microenvironments and cellular interactions in kidney regeneration and disease. Nat Commun. 2024;15(1):7010.","journal-title":"Nat Commun"},{"issue":"18","key":"1814_CR108","doi-asserted-by":"publisher","first-page":"4734","DOI":"10.1016\/j.cell.2021.08.003","volume":"184","author":"K Pelka","year":"2021","unstructured":"Pelka K, et al. Spatially organized multicellular immune hubs in human colorectal cancer. Cell. 2021;184(18):4734\u2013e475220.","journal-title":"Cell"},{"issue":"1","key":"1814_CR109","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41416-018-0327-z","volume":"120","author":"NA Giraldo","year":"2019","unstructured":"Giraldo NA, et al. The clinical role of the TME in solid cancer. Br J Cancer. 2019;120(1):45\u201353.","journal-title":"Br J Cancer"},{"issue":"5","key":"1814_CR110","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/s41590-025-02134-6","volume":"26","author":"M Shakiba","year":"2025","unstructured":"Shakiba M, Tuveson DA. Macrophages and fibroblasts as regulators of the immune response in pancreatic cancer. Nat Immunol. 2025;26(5):678\u201391.","journal-title":"Nat Immunol"},{"issue":"11","key":"1814_CR111","doi-asserted-by":"publisher","first-page":"101825","DOI":"10.1016\/j.xcrm.2024.101825","volume":"5","author":"C Denkert","year":"2024","unstructured":"Denkert C, et al. Molecular adaptation to neoadjuvant immunotherapy in triple-negative breast cancer. Cell Rep Med. 2024;5(11):101825.","journal-title":"Cell Rep Med"},{"issue":"1","key":"1814_CR112","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s40425-019-0675-0","volume":"7","author":"PF Wong","year":"2019","unstructured":"Wong PF, et al. Multiplex quantitative analysis of cancer-associated fibroblasts and immunotherapy outcome in metastatic melanoma. J Immunother Cancer. 2019;7(1):194.","journal-title":"J Immunother Cancer"},{"key":"1814_CR113","doi-asserted-by":"crossref","unstructured":"Peng YL et al. Single-cell transcriptomics reveals a low CD8(+) T cell infiltrating state mediated by fibroblasts in recurrent renal cell carcinoma. J Immunother Cancer, 2022. 10(2).","DOI":"10.1136\/jitc-2021-004206"},{"key":"1814_CR114","doi-asserted-by":"crossref","unstructured":"Song Y et al. Fibroblast growth factor receptor 3 mutation attenuates response to immune checkpoint blockade in metastatic urothelial carcinoma by driving immunosuppressive microenvironment. J Immunother Cancer, 2023. 11(9).","DOI":"10.1136\/jitc-2022-006643"},{"issue":"12","key":"1814_CR115","doi-asserted-by":"publisher","first-page":"102480","DOI":"10.1016\/j.xcrm.2025.102480","volume":"6","author":"B Wang","year":"2025","unstructured":"Wang B, et al. Targeting CTGF overcomes resistance to CSF1R inhibitors by preventing CAF activation in colorectal cancer. Cell Rep Med. 2025;6(12):102480.","journal-title":"Cell Rep Med"},{"issue":"1","key":"1814_CR116","doi-asserted-by":"publisher","first-page":"7165","DOI":"10.1038\/s41467-022-34744-1","volume":"13","author":"M Panagi","year":"2022","unstructured":"Panagi M, et al. Polymeric micelles effectively reprogram the tumor microenvironment to potentiate nano-immunotherapy in mouse breast cancer models. Nat Commun. 2022;13(1):7165.","journal-title":"Nat Commun"},{"issue":"1","key":"1814_CR117","doi-asserted-by":"publisher","first-page":"5413","DOI":"10.1038\/s41467-023-41141-9","volume":"14","author":"S Schutz","year":"2023","unstructured":"Schutz S, et al. Functionally distinct cancer-associated fibroblast subpopulations establish a tumor promoting environment in squamous cell carcinoma. Nat Commun. 2023;14(1):5413.","journal-title":"Nat Commun"},{"issue":"8","key":"1814_CR118","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1158\/0008-5472.CAN-15-3490","volume":"77","author":"G Valenti","year":"2017","unstructured":"Valenti G, et al. Cancer Stem Cells Regulate Cancer-Associated Fibroblasts via Activation of Hedgehog Signaling in Mammary Gland Tumors. Cancer Res. 2017;77(8):2134\u201347.","journal-title":"Cancer Res"},{"issue":"18","key":"1814_CR119","doi-asserted-by":"publisher","first-page":"3291","DOI":"10.1158\/0008-5472.CAN-22-1427","volume":"82","author":"E Timperi","year":"2022","unstructured":"Timperi E, et al. Lipid-Associated Macrophages Are Induced by Cancer-Associated Fibroblasts and Mediate Immune Suppression in Breast Cancer. Cancer Res. 2022;82(18):3291\u2013306.","journal-title":"Cancer Res"},{"issue":"4","key":"1814_CR120","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.cell.2018.01.028","volume":"172","author":"J Huelsken","year":"2018","unstructured":"Huelsken J, Hanahan D. A Subset of Cancer-Associated Fibroblasts Determines Therapy Resistance. Cell. 2018;172(4):643\u20134.","journal-title":"Cell"},{"issue":"1","key":"1814_CR121","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.immuni.2017.05.008","volume":"47","author":"L Onder","year":"2017","unstructured":"Onder L, et al. Lymphatic Endothelial Cells Control Initiation of Lymph Node Organogenesis. Immunity. 2017;47(1):80\u2013e924.","journal-title":"Immunity"},{"issue":"6","key":"1814_CR122","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.immuni.2019.05.008","volume":"50","author":"A Camara","year":"2019","unstructured":"Camara A, et al. Lymph Node Mesenchymal and Endothelial Stromal Cells Cooperate via the RANK-RANKL Cytokine Axis to Shape the Sinusoidal Macrophage Niche. Immunity. 2019;50(6):1467\u2013e14816.","journal-title":"Immunity"},{"issue":"9","key":"1814_CR123","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.ccell.2024.08.011","volume":"42","author":"L Cords","year":"2024","unstructured":"Cords L, de Souza N, Bodenmiller B. Classifying cancer-associated fibroblasts-The good, the bad, and the target. Cancer Cell. 2024;42(9):1480\u20135.","journal-title":"Cancer Cell"},{"issue":"2","key":"1814_CR124","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.cell.2022.12.028","volume":"186","author":"JR Lin","year":"2023","unstructured":"Lin JR, et al. Multiplexed 3D atlas of state transitions and immune interaction in colorectal cancer. Cell. 2023;186(2):363\u2013e38119.","journal-title":"Cell"},{"issue":"1","key":"1814_CR125","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41592-020-01033-y","volume":"18","author":"V Marx","year":"2021","unstructured":"Marx V. Method of the Year: spatially resolved transcriptomics. Nat Methods. 2021;18(1):9\u201314.","journal-title":"Nat Methods"},{"issue":"5","key":"1814_CR126","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/s41587-021-01139-4","volume":"40","author":"V Kleshchevnikov","year":"2022","unstructured":"Kleshchevnikov V, et al. Cell2location maps fine-grained cell types in spatial transcriptomics. Nat Biotechnol. 2022;40(5):661\u201371.","journal-title":"Nat Biotechnol"},{"issue":"8","key":"1814_CR127","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1158\/0008-5472.CAN-21-2778","volume":"82","author":"R Wei","year":"2022","unstructured":"Wei R, et al. Ketogenesis Attenuates KLF5-Dependent Production of CXCL12 to Overcome the Immunosuppressive Tumor Microenvironment in Colorectal Cancer. Cancer Res. 2022;82(8):1575\u201388.","journal-title":"Cancer Res"}],"container-title":["Journal of Hematology &amp; Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13045-026-01814-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-026-01814-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13045-026-01814-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T01:04:58Z","timestamp":1787792698000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13045-026-01814-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":127,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1814"],"URL":"https:\/\/doi.org\/10.1186\/s13045-026-01814-6","relation":{},"ISSN":["1756-8722"],"issn-type":[{"value":"1756-8722","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"19 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"59"}}